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Ion Channels: Structural Basis for Function 
and Disease 
Steve A. N. Goldstein 
Ion channels are ubiquitous proteins that mediate nervous and muscular function, rapid transmem- 
brane signaling events, and ionic and fluid balance. The cloning of genes encoding ion channels has 
led to major strides in understanding the mechanistic basis for their function. These advances have 
shed light on the role of ion channels in normal physiology, clarified the molecular basis for an 
expanding number of diseases, and offered new direction to the development of rational therapeutic 
interventions. 
Copyright 9 1996 by W.B. Saunders Company 
on channels reside in the membranes of all 
cells and control their electrical activity. 1
These proteins underlie subtle biological events 
such as the response of a single rod cell to a 
beam of light, the activation of a T cell by its 
antigen, and the fast block to polyspermy of a 
fertilized ovum. They also mediate spectacular 
events like heart beats, systemic fluid and electro- 
lyte homeostasis, and our memories. Over the 
past 40 years, increasingly sensitive lectrophysi- 
ological methods have allowed characterization 
of channel function at remarkable resolution- 
single channel molecules can be observed in real 
time (Fig 1A). However, it is only in the last few 
years with the application of molecular genetic 
technology that we have begun to discern the 
structural basis for ion channel function. Clon- 
ing of genes for channels and their regulatory 
subunits has revealed amino acid sequences and 
made feasible studies of structure and function 
that were impossible with native tissues alone. 
Recent advances in our understanding of the 
mechanistic underpinnings for normal function 
of sodium (Na +) and potassium (K +) channels 
are discussed in this article. These insights have 
clarified the etiology for an expanding number  
of disease states and allow disorders mediated 
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by ion channels to be divided into two broad 
mechanistic groups: those resulting from loss of 
channel function and those consequent to gain 
of channel function. Three exemplary patho- 
physiological correlates are examined, Long QT 
syndrome, Liddle's syndrome and pseudohypo- 
aldosteronism type 1 (leading to life-threatening 
cardiac rhythm disturbances, ystemic hyperten- 
sion, and hypotension, respectively). Future 
challenges for ion channel research are consid- 
ered. 
Ion Channel  Funct ion:  Gating and Ion 
Select iv ity 
Ion channels perform two operations. First, they 
open and close in response to specific stimuli; 
this process is called "channel  gating." Second, 
they catalyze the flux of specific ions across the 
membrane,  an activity referred to as " ion selec- 
tive conduction." Some channels are ligand- 
gated. Thus, binding of cGMP to a cyclic-nucleo- 
tide gated (CNG) channel in the retina leads to 
a conformational change in channel structure 
and a shift from a closed, nonconducting chan- 
nel state to an open state that is maintained as 
long as cGMP is bound. Other ion channels are 
voltage-gated. The single Na + channel shown in 
Fig 1A undergoes a series of state transitions 
when the membrane is depolarized from its rest- 
ing level ( -80  mV) to a more positive potential 
( -10  mV). The channel moves first from a 
closed (or resting) state to an open state that 
allows Na + to flow into the cell; it proceeds to 
another nonconducting conformation, the inac- 
tive state, in which it sits silently despite main- 
tained membrane depolarization (Fig 1B). 
520 Seminars in Perinatology, Vol 20, No 6 (December), 1996: pp 520-530 
Ion Channels: Basis for Function and Disease 521 
A 
closed ~ 
open 
-10 mV 
-80 mV I 
B 
Resting .,9[,m=,~ Open ~ Inactivated 
C 
Membrane ~,1 2 
Voltage 9 #~JIIpsiJl~11sis~# ....... ) 
I Current ( ) .4  . . . .  j . . . .  "" 
Potassium / 
Current 
( ) 
Figure 1. Single channel recording ofa Na + channel 
with a gating scheme and a diagram of a cardiac action 
potential with two contributing channel currents. (A) 
Single channel recording from a cardiac voltage-gated 
Na + channels (courtesy of Ted Cummins and Fred 
Sigworth, Yale University). In response to a change in 
voltage from -80 mV to -10 mV, the channel moves 
from resting to open conformation and then to an 
inactive state. (B) Scheme for gating of an inactivating 
voltage-gated channel. (C) Diagram of the phases of 
a cardiac Purkinje cell action potential with currents 
through two contributing channels superimposed, 
based on Fozzard. 6~ The channel currents associated 
with the five phases of the action potential are: phase 
0, rapid depolarization-IN, and I(:,; phase 1, fast repo- 
larization-It,,; phase 2, plateau-It,; phase 3, delayed re- 
polarization-I~,, I~r; phase 4, pacemaker depolariza- 
tion-Ira, If. 
An open ion channel forms a water-filled con- 
duction pore across the membrane bringing the 
external and intracellular solutions into continu- 
ity. Ions passively diffuse through the pore in a 
direction determined solely by differences in ion 
concentration and electrical potential across the 
membrane. This does not indicate that channel 
proteins are inert scaffolding; the number and 
type of ions that move through a channel reveal 
its influence. Thus, some K + channels catalyze 
the flow of 100,000,000 K+ ions each second 
through a single channel complex, yet maintain 
a preference for K + over Na § of 10,000 to 1.2 We 
will consider the dramatic progress in under- 
standing of the molecular basis for opening and 
inactivation of voltage-gated channels as well as 
the channel regions that mediate ion conduc- 
tion and selectivity. 
Ion  Channe l  Funct ion :  The  Cardiac 
Act ion  Potent ia l  
A cell's electrical behavior is determined by the 
gating and selectivity attributes of its ion chan- 
nels. :~-5 In the heart, cells of the conduction path- 
way exhibit a pattern of cyclical excitability with 
five phases. A Purkinje cell action potential and 
its two primary channel currents are schematized 
in Fig 1C. Phase 0 is an explosive rise in mem- 
brane potential due to a rush of Na+into the 
cell (down its concentration gradient) through 
voltage-gated Na + channels that open with mem- 
brane depolarization; these channels then rap- 
idly inactivate (Fig 1A, B). Phase 1 is a brief repo- 
larization step mediated by voltage-gated K + 
channels that open with depolarization and, like 
phase 0 Na + channels, rapidly inactivate. Be- 
cause outward flow of K + (down its concentra- 
tion gradient) makes the cell interior more nega- 
tive, opening K § channels hifts the cell toward 
more negative potentials. Phase 2, the plateau 
in the action potential, is coincident with myo- 
cardial contraction and results from the cumula- 
tive activity of a number of channel and carrier- 
type transporters. The duration of phase 2 is 
determined by voltage-gated K + channels that 
open with a delay in response to membrane de- 
polarization and remain open until the mem- 
brane is again hyperpolarized (Fig 1C). These 
delayed outward K + currents return the mem- 
brane to its resting potential during phase 3 and 
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allow the heart to relax. Phase 4, the pacemaker 
potential, is a slow rise in membrane potential 
attributed to closing of other K + channels and 
instigates the next cycle of excitation and con- 
traction. In broad outline, cardiac excitation re- 
sults from rapid, voltage-dependent gating of 
Na + channels, delayed, voltage-dependent gat- 
ing of K + channels, and the ability of both chan- 
nels to discriminate between Na + and K § ions. 
Cloning of Genes Encoding Ion Channels 
Identification of the structural determinants of 
gating and selectivity followed cloning of the 
genes encoding ion channels. The first Na § 
channel gene was isolated by a direct biochemi- 
cal approach; channel protein was purified from 
the electric organ of the Electrophorus electricus eel 
in sufficient quantity to allow production of anti- 
channel antibodies, and these were subsequently 
used to screen and isolate the gene from an eel 
cDNA expression library. 6K + channels have no 
high abundance tissue source; the first K + chan- 
nel gene was isolated after its identification as 
the cause of a motion disorder in mutant fruit 
flies. 7-9 Scores of related Na + and K + channel 
genes and their human homologues were then 
identified based on their homology to the se- 
quences of these first two genes) ~ More recently, 
novel ion channel genes have been isolated by 
screens for expression of channel function 
rather than DNA sequence homology u'14 and by 
computer analysis of the rapidly expanding data- 
base of genomic and expressed nucleotide se- 
quences for channel-like motifs. 15A6 
Classification of Ion Channels by 
Structure 
Once genes for voltage-gated Na +, Ca 2+, and K + 
channels and ligand-gated CNG channels were 
isolated, their membership in an extended mo- 
lecular superfamily was revealed. Marked by simi- 
larities in primary sequence and predicted mem- 
brane topology, voltage-gated Na + and Ca 2+ 
channels contain four homologous domains in 
tandem, each with six predicted membrane- 
spanning segments (Fig 2A). Voltage-gated K + 
channel subunits and CNG channel subunits are 
similar in size and topology to a single Na + chan- 
nel domain (Fig 2B). Inward rectifier K +chan-  
nels and epithelial Na + channels share a pro- 
posed two transmembrane topology (Fig 2C), 
whereas the recently identified outward rectifier 
(Fig 2D) and open rectifier K + channel subunits 
(Fig 2E) are built with two domains similar to 
those observed in previously identified K + chan- 
nels. 
Assigning Structure to Function: 
Voltage-Dependent Gating 
Channel regions that participate in gating and 
ion selectivity were first suggested by comparison 
of the amino acid sequences predicted from 
each newly isolated gene. 6avas Candidate regions 
were then evaluated and influential residues 
identified by studying the functional effects of 
site-directed mutations. 
Resting to Open Transition 
Hodgkin and Huxely ~ first proposed that 
changes in voltage might cause the movement 
of charged "gating particles" within nerve mem- 
branes to turn Na + and K + conductances on and 
off. Thirty years later, cloning revealed that volt- 
age-gated channels carry a novel charge-con- 
taining motif  not observed before in membrane 
proteins: at every third or fourth position in the 
fourth predicted transmembrane s gments ($4), 
a positive arginine or lysine residue is present. 
That movement of these $4 charges might medi- 
ate the effects of voltage on channel activation 
gained early support 19'2~ and has now been firmly 
established. 91,22 
Yang et al 2x'23 investigated the $4 segment in 
the fourth homologous domain (D4) of a hu- 
man skeletal muscle voltage-gated Na + channel. 
They started with a channel mutant, first identi- 
fied in patients with paramyotonia congenita, 24 
in which the initial arginine in $4/D4 is mutated 
to cysteine. When they added a cysteine-specific 
reagent o the external solution, the channel be- 
came covalently modified and its gating was 
changed. Modification was speeded by mem- 
brane depolarization as if voltage caused out- 
ward movement of the $4/D4 segment and 
greater exposure of the cysteine to reagent in 
the bath. Study of each of the seven remaining 
positively charged $4/D4 residues upported the 
hypothesis that this region held the long-sought 
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Figure 2. Probable membrane topologies of ion channel a-subunits. (A) Voltage-gated Na + and Ca 2§ channels; 
(13) voltage-gated K + channels and CNG-gated channels; (C) inward rectifier K + channels and epithelial Na + 
channels; (D) two P domain outward rectifier K § channeltS'16; and (E) two P domain open rectifier K + channel. ~4 
gating particles~l; whereas wild-type channels 
were unaffected by cysteine-specific probes, 
channels with cysteine at the 1st, 2nd, or 3rd 
charged site altered gating. Notably, the second 
and third sites were modified only under some 
circumstances: external reagent had no effect if 
the membrane was hyperpolarized (and chan- 
nels were at rest), but acted on depolarization; 
moreover, internal reagent had no effect if the 
membrane was depolarized, but acted on hyper- 
polarization. These sites seemed to move com- 
pletely across the membrane; exposed inside the 
membrane at rest, they gained exposure to the 
external solution with depolarization. 
How gating charge movements are translated 
into channel opening is not yet known. However, 
a hypothesis for the channel's tructure near $4 
suggests that the first three charged sites move 
into continuity with the external solution (or 
into a vestibule large enough to accommodate 
the cysteine probes which are ~6~ in diame- 
ter), whereas the fourth charged site remains 
exposed to the internal compartment. In c~-heli- 
cal conformation, the third and fourth sites 
could be separated by as little as 4.5~ (if ex- 
tended, by no more than 10 to l l~ Thus, gat- 
ing charges eem to travel through short canals 
(canaliculi) in the protein to reach vestibules in 
contact with cellular or external solution and, 
thereby, limit their unfavorable interaction with 
membrane lipids (Fig 3A).25 This suggests how 
gating charges move completely across 40~ of 
hydrophobic ell membrane injust a few 10 mil- 
lionths of a second: only some $4 charges tra- 
verse the membrane,  and their movement isover 
a limited distance. A similar model for the role 
of the $4 in voltage-gated K § channel function 
has been cogently argued. ~6 
Open to Inactive Transition 
The inrush of Na + in phase 0 of the cardiac 
action potential is explosive and regenerative be- 
cause Na + influx drives the membrane to more 
positive potentials, leading even more voltage- 
gated Na + channels to open. The process is re- 
strained by transition of the channels to an inac- 
tive state a few milliseconds after they open (Fig 
1A). Armstrong and Bezanilla first proposed a 
"ball and chain" model for fast inactivation 
based on their observation that internal protease 
treatment produced channels that did not inacti- 
vate. 27 They suggested that protease removed a 
portion of the channel (the ball) that moved 
into the channel pore after it was open to physi- 
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cally block ion conduction (Fig 3B). In fact, this 
simple mechanism seems to be operative in both 
K + and Na + channels. In Shaker K + channels, 
the intracellular amino-terminus of the pro- 
tein functions as a tethered open channel 
blocker. 28'29 When these residues are removed 
by protease treatment (or by genetic deletion), 
the channels no longer show fast inactivation. 
Remarkably, application of the deleted "inacti- 
vation ball" as a soluble peptide to the intracellu- 
lar face of the channel restores inactivation. 
Moreover, varying the length of the "chain" of 
residues between the "ball" and the rest of the 
channel varies the speed of inactivation. In Na + 
channels, it is the cytoplasmic residues linking 
homologous domains III and IV that are critical 
for fast inactivation and function to block open 
channe ls .  19'3~ This was shown first by inhibition 
of inactivation by internally applied peptide-spe- 
cific antibodies and, subsequently, by site-di- 
rected mutation. Deletion of residues mediating 
fast inactivation often reveals a slow inactivation 
process that proceeds over 100's of milliseconds 
and is mediated by the $5, P, and $6 domains in 
K + channels. 32 
Accessory Subunits 
The core (or ol) subunits depicted in Fig 2 can 
function by themselves; however, in most cells 
they are expressed in association with one or 
more accessory subunits. These additional sub- 
units are essential to integrated cellular func- 
tion. They regulate channel expression levels, 
modify functional activity, and influence phar- 
macological sensitivity. Some accessory subunits 
carry an inactivation ball and produce rapidly 
inactivating channels when assembled with K + 
channel ol-subunits that normally remain open 
with maintained epolarization. For anexcellent 
recent review, see Catterall. 33 
Assigning Structure to Function: Ion 
Selectivity 
Voltage-gated Na +, Ca 2+, and K + channels and 
CNG channels how fourfold symmetry. In each, 
a single conduction pore is formed, either 
through folding of four homologous domains, 
or aggregation of four independent subunits. 
The residues linking every fifth and sixth mem- 
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Figure 3. Schematic representations of channel struc- 
tures involved in channel gating and pore formation. 
(A) The $4 segment of the Na + channel fourth homol- 
ogous domain is diagrammed indicating the proposed 
relationship of the gating charges to the $4 canalicu- 
lus in the resting and open conformations, based on 
reference 21; (B) the "ball and chain" model of K + 
channel inactivation suggests the amino-terminal resi- 
dues act as a tethered blocker that enters and occludes 
the internal channel vestibule after the channel is 
open, based on references 28 and 29. (C) The amino 
acids in the $5-$6 linker region of the Shaker K + chan- 
nel that are pore-forming are indicated by their single 
letter codes; residues that are critical to charybdotoxin 
binding have an asterisk (*), the sites critical to exter- 
nal tetraethylammonium on (TEA) binding are out- 
lined, a site critical to internal TEA binding is under- 
lined; the P domain "signature sequence" residues 
are bolded. 
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brane-spanning segment contribute to pore for- 
mation (P domains; Fig 2) and are arrayed cen- 
trally as four "pore loops". 34 Pores are the 
catalytic "active sites" of ion channels, and iden- 
tification of P domains has been a major recent 
step in understanding the structural basis for 
channel function, ls'35-38 
The first clue to which residues formed the 
pore in K § channels came from studies of block- 
ade of Shaker K + channels by the scorpion 
venom neurotoxin, charybdotoxin. Previously, 
functional studies had indicated that charybdo- 
toxin interacted with negatively charged sites on 
K + channels and inhibited by physically occlud- 
ing the external pore entryway. "s~41 Now, system- 
atic point mutation of negative residues in 
Shaker revealed that a unique glutamate residue 
in the channel region linking transmembrane 
stretches $5 and $6 was one such interaction site 
and was probably near the channel pore35; resi- 
dues across this $5-$6 linker region were subse- 
quently shown to be critical to toxin binding (Fig 
3C) 42-44 
That the $5-$6 linker crossed the membrane 
to form the ion conduction pathway was shown 
by identification of two binding sites in this re- 
gion for tetraethylammonium ion (TEA), one 
extracellular and one intracellular/6'37 This was 
a surprising result because hydropathy analysis 
had suggested the region was likely to form a 
completely extracellular protein loop. In dra- 
matic support for this model, a chimeric channel 
with 24 of its $5-$6 linker residues replaced by 
linker sites from another channel showed pore 
characteristics of the donor channel; the chi- 
mera showed high single channel conductance 
(unlike the native channel), high sensitivity to 
internal TEA (rather than low), and low sensitiv- 
ity to external TEA (rather than high).3s Notably, 
2 years in advance of any of these experimental 
findings, evaluation of the Na + channel se- 
quence had led Guy and Seetharamulu to pro- 
pose from first principles that the residues link- 
ing $5 and $6 would dip into the membrane to 
form the pore. Is Comparison of sequences of 
cloned K + channels and detailed studies of chan- 
nels with point mutations in the P domain al- 
lowed Heginbotham et al to identify a "signature 
sequence" of eight highly conserved residues in 
the P domains of all K+-selective ion channels 
(Fig 3C).45,46 
Although membrane proteins like channels 
are not yet readily amenable to crystallization 
and direct structural determination, peptide tox- 
ins have provided an indirect means to assess 
spatial ocations of pore residues. This has been 
achieved by combining the known three-dimen- 
sional structure of the toxins and identified sites 
of toxin-channel interaction. 47'4s From a first 
crude image of the Shaker K + channel vestibule 
using charybdotoxin and a first weak contact 
pair, 44 a sixth coupling pair and the largest inter- 
action energy yet observed was recently re- 
ported. 49 The significance of that report lies in 
the fact that the contact was predicted from a 
pair-driven model of the pore and, so, validated 
its conclusions. 
Channel Heterogeneity 
The large variety of channel currents observed 
in vivo results first from the many separate genes 
encoding pore-forming channel subunits. This 
diversity is increased by alternative RNA splic- 
ing 5~ and RNA editing, 51'52 which modify the en- 
coded primary structure of the core subunits 
after transcription. Diversity is even more pro- 
nounced in channels that form as multimeric 
complexes because subunits can associate in var- 
ied combinations. Thus, voltage-gated K + chan- 
nels assemble ither as homotetramers or as het- 
eromeric mixtures of two or more subunit types. 
Heteromeric hannels exhibit new characteris- 
tics in gating, conduction, and pharmacology53; 
some, like cardiac KAch channels, require hetero- 
meric association to form functional channel 
complexes. 54Another degree of functional diver- 
sity is provided by modulatory accessory subunits 
that associate with the pore-forming core sub- 
units. 
Regulation of Channel Function 
Channels are regulated in a cell-by-cell fashion; 
thus, adjacent cells in a tissue can express differ- 
ent channels or channel subtypes; for an excel- 
lent review see Levitan and Kaczmarck. 55 Speci- 
ficity is achieved at multiple levels: which core 
and accessory subunits are expressed is con- 
trolled at the level of gene transcription, RNA 
editing, and RNA translation. Variation in chan- 
nel levels and subtypes is observed with develop- 
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Table 1o Diseases Mediated by Ion Channels 
Mechanism Disease Channel Reference 
Loss of function 
Low levels of surface xpression 
Unstable protein 
Autoimmune degradation 
Open poorly, inactivate quickly 
Decreased single channel conductance 
Channel down-regulation 
Decreased agonist affinity 
Blockade by drugs or poisons 
Altered channel selectivity 
No channel function-undetermined 
Gain of function 
Open too readily 
Inactivate slowly 
High open probability 
Activated by drugs or poisons 
Channel up-regulation 
Cystic fibrosis CFTR 70, 
Myasthenia gravis AchR 72 
Lambert-Eaton syndrome VGCa 73 
Acquired myotonia VGK 74 
PHHI KATP 75 
Thomsen's myotonia CLC-1 76 
Becker's myotonia 
Cystic fibrosis CFTR 77 
Cystic fibrosis CFTR 78 
Myasthenic syndrome-LAFC AChR 79 
Long QT syndrome HERG 60 
Weaver mice VGK 58 
Dent's disease, XRN, XLRH CLC-5 80 
PHA-1 a-ENaC 65 
HYPP SCN4a 81 
Paramyotonia congenita SCN4a 81 
Long QT syndrome SCN5a 82 
Liddle's syndrome ENaC 62, 
Malignant hyperthermia RYR 83, 
Cholinesterase inhibitors AChR 85 
Neuronal cell death in stroke NMDA 86 
71 
63 
84 
Abbreviations: CFTR, cystic fibrosis transmembrane regulator; AChR, acetylcholine receptor channel; VGCa, voltage-gated 
calcium channel; VGK, voltage-gated potassium channel; PHHI, persistent hyperinsulinemic hypoglycemia of infancy; KATP, 
ATP senstive potassium channel; CLC1, voltage-gated chloride channel type 1; HERG, human eag-related gene, a voltage- 
gated K + channel; XRN, X-linked recessive nephrolithiasis; XLRH, X-linked recessive hypophosphatemic rickets; PHA-1, 
pseudohypoaldosteronism type 1; LAFC, low-affinity, fast channel congenital myasthenic syndrome; HYPP, hyperkalemic 
periodic paralysis; SCN4a, a human skeletal muscle voltage-gated sodium channel; SCN5a, a human cardiac voltage-gated 
Na + channel; ENaC, epithelial Na + channel; RYR, Ryanodine receptor, a calcium release channel; NMDA, N-methyl-D- 
aspartate r ceptors, calcium channels. 
mental stage, cell cycle, and external stimula- 
tion. Moreover, some channels are accurately 
localized to defined subcellular sites (such as mo- 
tor end plates or dendrites), whereas others are 
sorted to apical or basolateral surfaces in polar- 
ized cells to achieve vectorial transport. Many 
channels are also subject o strict modulation by 
second messenger levels or by direct phosphory- 
lation. 56'57 These mechanisms underlie a diverse 
repertoire of ion channel functions observed in 
normal cellular physiology. 
Channel Dysfunction and Disease 
As the molecular basis for ion channel function 
has been revealed, so has the basis for an increas- 
ing number of ion channel-mediated diseases. 
Table 1 categorizes disorders of known etiology 
into two groups: those resulting from loss of 
channel function and those due to gain of chan- 
nel function. Loss of function can be a result of 
low levels of channel protein in the membrane. 
Thus, the most common variant of cystic fibrosis 
is marked by inherent instability of the 
CFTRA508 chloride channel protein leading to 
its rapid intracellular degradation. Autoantibod- 
ies mediate channel degradation i  myasthenia 
gravis, Lambert-Eaton syndrome, and one form 
of acquired myotonia (Table 1). Loss of function 
disorders are also observed when channels reach 
the membrane but show decreased activity. Ex- 
amples in humans include persistent hyperinsu- 
linemic hypoglycemia of infancy (PPHI) and the 
inherited congenital myotonias (Thomsen's, 
Becker's) in which channels open poorly or for 
too short a time. Other loss of function disorders 
are the result of decreased single channel con- 
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ductance, inappropriate down-regulation, de- 
creased agonist affinity, and blockade by drugs 
or poisons (Table 1). Weavermice have a neuro- 
degenerative disorder characterized by K + chan- 
nels that open but are no longer selective. 5sNot 
yet reported for ion channels are diseases re- 
sulting from diminished transcription and trans- 
lation or rapid degradation owing to improper 
secondary modification. 
Disorders resulting from a gain of channel 
function include hyperkalemic periodic paralysis 
(HYPP) in which channels open too readily, and 
paramyotonia congenitia (PC) in which they in- 
activate too slowly. Other gain of function dis- 
eases are due to channels that have an abnor- 
mally high open probability as a result of 
mutations or exogenous activation by drugs or 
poisons (Table 1). The pathophysiology of neu- 
ronal cell death in stroke seems to involve dys- 
functional up-regulation of NMDA Ca 2+ chan- 
nels (Table 1). No disorders are yet known to 
result from protein overproduction, diminished 
degradation, or increased single channel con- 
ductance. An excellent review of hereditary dis- 
eases of skeletal muscle ion channels is pub- 
lished. 59 
Correlation of Channel Function and 
Disease: Three Examples 
Long QT syndrome (LQTS) is a cardiac disorder 
that predisposes the heart to torsade de pointes, 
a ventricular arrhythmia that can degenerate 
into ventricular fibrillation and cause sudden 
death. It can be acquired, most commonly as 
a side effect of treatment with class IA or III 
antiarrhythmic medications, or inherited. The 
electrocardiograms of affected individuals how 
an abnormally prolonged repolarization i terval 
(QTc). Recent molecular studies have estab- 
lished that two forms of inherited LQTS result 
from mutations in the genes encoding cardiac 
ion channels. SCN5a on chromosome 3 encodes 
the cardiac voltage-gated Na + channel that un- 
derlies the rapid rising phase of the cardiac ac- 
tion potential (Fig 1B, phase 0). Mutations in 
SCN5a produce channels with destabilized inac- 
tivation gates. Mutant channels open normally, 
but are not stable in the inactivated state; by 
reopening repetitively during depolarization, 
the channels prolong the cardiac action poten- 
tial. A different mechanism underlies LQTS re- 
suiting from mutation in the human eag-related 
gene (HERG) locus on human chromosome 7.
HERG encodes the core subunit of a K + channel 
and mediates a cardiac delayed-rectifier K + cur- 
rent, II~ critical to myocardial action potential 
repolarization (Fig 1B, phase 3). A number of 
mutations in HERG channels have now been 
identified in individuals with LQTS: all act to 
reduce channel function and prolong action po- 
tential duration. Drug-induced LQTS also results 
from decreased HERG channel function but is 
due to channel blockade. 6~ These mechanistic 
insights have facilitated new therapeutic ap- 
proaches. LQTS resulting from mutations in 
SCN5a (gain of function) has proven amenable 
to treatment with Na § channel blockers, whereas 
individuals with mutations in HERG (loss of 
function) have corrected their repolarization ab- 
normalities in response to modest increases in 
extracellular K + concentration. 6~ 
Liddle's syndrome (pseudoaldosteronism) is 
an autosomal dominant disorder characterized 
by early onset of moderate to severe hyperten- 
sion. Lifton and colleagues recently showed that 
this disorder esults from mutations in subunits 
of the amiloride-sensitive epithelial Na § channel 
(ENaC) of the kidney and that mutations lead 
to constitutive channel activation (gain of func- 
t ion)Y 64 These channels are formed by co-as- 
sembly of o~,/3, and 7 subunits. Affected patients 
have been found to carry mutations that lead to 
deletion of the cytoplasmic arboxyl termini of 
their/3 or 7 ENaC subunits. Biophysical analysis 
of one /3 subunit mutation revealed channels 
with normal single channel conductance, ion se- 
lectivity and sensitivity to amiloride blockade, 
but excess channel openings in membrane 
patches. Because reabsorption of Na + through 
ENaC is regulated by aldosterone, a process that 
is a major determinant of net Na + reabsorption 
by the kidney, increased channel activity leads 
to increased Na + reabsorption and hypertension 
in affected individuals. 
Autosomal recessive pseudohypoaldosteron- 
ism type 1 (PHA-1) is characterized by life-threat- 
ening dehydration in the neonatal period. It is 
characterized by marked hypotension, salt wast- 
ing, elevated K + levels, metabolic acidosis, and 
marked elevation in plasma renin and aldoste- 
rone levels. In this case, Lifton and colleagues 
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showed the disorder to result from mutations in 
or/3 ENaC subunits leading to loss of channel 
function. 65 ENaC dysfunction seems to cause the 
disorder by facilitating renal tubular Na + loss. 
This leads to a secondary defect in secretion of 
K + and H + ions and stimulation of the renin- 
angiotensin system. However, salt reabsorption 
is not increased because the ENaC target is unre- 
sponsive. 
Future Research Directions 
An array of medical conditions are potentially 
amenable to treatment by agents that act on ion 
channels. 66 Abnormal ion channels are directly 
responsible for the pathophysiology of some dis- 
eases. In other cases, normal ion channels are 
inappropriately regulated. To develop rational 
therapeutic interventions targeted at ion chan- 
nels, a series of unanswered queries lies ahead. 
Recognized currents that are key to tissue func- 
tion must be identified at the molecular level 
(for example, the If current that mediates car- 
diac pacemaker function67'68). The  biochemical 
rules that govern subunit association must be 
defined. The constituent subunits of hetero- 
meric complexes that mediate function in vivo 
need to be delineated. The pattern of functional 
expression of channel subtypes through develop- 
ment needs to be described. Regulation and 
modulation of ion channel function in vivo re- 
main poorly elucidated. To understand the 
structural basis for channel function, accurate 
three-dimensional information about the struc- 
ture of ion channels is required. It seems likely 
that the mechanisms of most channel-mediated 
disorders are yet to be discerned, and that many 
diseases are yet to be appropriately attributed to 
ion channel dysfunction. To achieve therapies 
based on mechanistic nsight, we have many bar- 
riers to surmount. The rapid progress made in 
the last few years makes such a goal seem fea- 
sible. 
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